Products
Investing
Resources
Support
Sun Pharmaceutical Industries Limited (SUNPHARMA)
₹1,823.2
INR+34.40(+1.92%)
As of April 30, 2025 7:52:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹443372.96 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹411598.93 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
38.37
Forward P/E
Price to Earnings ratio based on forecasted earnings
56.03
PEG Ratio
Price/Earnings to Growth ratio
56.03
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
8.59
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
79.60%
Operating Margin
Operating income as a percentage of revenue
26.05%
Return on Equity
Net income as a percentage of shareholders' equity
14.27%
Revenue (TTM)
Total revenue over trailing 12 months
₹51602.50 Cr+10.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹16465.19 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹47.72+15%
Balance Sheet
Total Cash
Total cash and short-term investments
₹20122.19 Cr
Total Debt
Total short-term and long-term debt
₹2571.95 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
3.71%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1377.2 - ₹1960.35
Beta
Measure of stock's volatility compared to the market
0.55
Shares Outstanding
Total number of shares issued by the company
₹239.93 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.16%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.86%
Payout Ratio
Percentage of earnings paid as dividends
28.30%